Menstrual suppression: current perspectives

References

• EdelmanAGalloMJensenJNicholsMSchulzKGrimesDContinuous or extended cycle vs cyclic use of combined oral contraceptives for contraceptionCochrane Database Syst Rev20053CD00469516034942
   PubMedGoogle Scholar
• DapuntOLoewitKA form of therapeutic amenorrhea. Acyclic long-term therapy with so-called ovulation inhibitors in the same constant dosageZ Geburtshilfe Perinatol196616617286 German
   Google Scholar
• LarosRKJrTherapeutic amenorrhea in hematologic disordersObstet Gynecol19713845895935107182
   PubMed Web of Science ®Google Scholar
• GladwellMJohn Rock’s ErrorThe New Yorker3102000New York, New YorkThe New Yorker
   Google Scholar
• KistnerRThe treatment of endometriosis by inducing pseudopregnancy with ovarian hormonesFertil Steril195910539556
   Web of Science ®Google Scholar
• CoutinhoEMSegalSJIs Menstruation Obsolete?New York, NYOxford University Press1999
   Google Scholar
• SulakPJCressmanBEWaldropEHollemanSKuehlTJExtending the duration of active oral contraceptive pills to manage hormone withdrawal symptomsObstet Gynecol19978921791839015017
   PubMed Web of Science ®Google Scholar
• ThomasSLEllertsonCNuisance or natural and healthy: should monthly menstruation be optional for women?Lancet3112000355920792292410752720
   PubMed Web of Science ®Google Scholar
• EdelmanAMenstrual nirvana: amenorrhea through the use of continuous oral contraceptivesCurr Womens Health Rep20022643443812429077
   PubMedGoogle Scholar
• KaunitzAMMenstruation: choosing whether … and whenContraception200062627728411239613
   PubMed Web of Science ®Google Scholar
• NelsonALThe pill at 40–a new look at a familiar method. Whose pill is it, anyway?Fam Plann Perspect2000322899010779240
   PubMedGoogle Scholar
• LoudonNBFoxwellMPottsDMGuildALShortRVAcceptability of an oral contraceptive that reduces the frequency of menstruation: The tri-cycle pill regimenBr Med J197726085487490890363
   PubMed Web of Science ®Google Scholar
• SulakPJKuehlTJOrtizMShullBLAcceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptomsAm J Obstet Gynecol200218661142114912066088
   PubMed Web of Science ®Google Scholar
• CachrimanidouACHellbergDNilssonSWaldenstromUOlssonSESikstromBLong-interval treatment regimen with a desogestrel-containing oral contraceptiveContraception19934832052168222651
   PubMed Web of Science ®Google Scholar
• MillerLHughesJContinuous administration of 100 ug levonorgestrel and 20 ug ethinyl estradiol: a randomized controlled trialObstet Gynecol200299Suppl77177811978286
   PubMed Web of Science ®Google Scholar
• WiegratzIHommelHHZimmermannTKuhlHAttitude of German women and gynecologists towards long-cycle treatment with oral contraceptivesContraception2004691374214720618
   PubMed Web of Science ®Google Scholar
• BenagianoGCarraraSFilippiVSafety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptivesPatient Prefer Adherence2009313114319936155
   PubMed Web of Science ®Google Scholar
• GlasierAFSmithKBvan der SpuyZMAmenorrhea associated with contraception–an international study on acceptabilityContraception20036711812521650
   PubMed Web of Science ®Google Scholar
• AndristLCHoytAWeinsteinDMcGibbonCThe need to bleed: women’s attitudes and beliefs about menstrual suppressionJ Am Acad Nurse Pract2004161313715008036
   PubMedGoogle Scholar
• MakuchMYOsisMJPettaCAde PaduaKSBahamondesLMenstrual bleeding: perspective of Brazilian womenContraception201184662262722078192
   PubMed Web of Science ®Google Scholar
• SchlaffWDLynchAMHughesHDCedarsMISmithDLManipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppressionAm J Obstet Gynecol2004190494395115118618
   PubMed Web of Science ®Google Scholar
• LegroRSPauliJGKunselmanAREffects of continuous versus cyclical oral contraception: a randomized controlled trialJ Clin Endocrinol Metab200893242042918056769
   PubMed Web of Science ®Google Scholar
• AndersonFDFeldmanRReapeKZEndometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placeboContraception2008772919618226671
   PubMed Web of Science ®Google Scholar
• Society for Menstrual Cycle ResearchMenstrual SuppressionFredonia, NYSociety for Menstrual Cycle Research2007 Available from: http://menstruationresearch.org/wp-content/uploads/2009/07/SMCRposition06082007.pdfAccessed 28 May, 2014
   Google Scholar
• StewartFHKaunitzAMLaguardiaKDKarvoisDLFisherACFriedmanAJExtended use of transdermal norelgestromin/ethinyl estradiol: a randomized trialObstet Gynecol200510561389139615932834
   PubMed Web of Science ®Google Scholar
• BracheVPayanLJFaundesACurrent status of contraceptive vaginal ringsContraception201387326427223040125
   PubMed Web of Science ®Google Scholar
• KernsJDarneyPVaginal ring contraceptionContraception201183210711521237335
   PubMed Web of Science ®Google Scholar
• JacobsonJCLikisFEMurphyPAExtended and continuous combined contraceptive regimens for menstrual suppressionJ Midwifery Womens Health201257658559223217068
   PubMed Web of Science ®Google Scholar
• BahamondesLBahamondesMVNew and emerging contraceptives: a state-of-the-art reviewInt J Womens Health2014622123424570597
   PubMedGoogle Scholar
• MattesonKARahnDDWheelerTL2ndNonsurgical management of heavy menstrual bleeding: a systematic reviewObstet Gynecol2013121363264323635628
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationFDA Bulletin101972
   Google Scholar
• LinKBarnhartKThe clinical rationale for menses-free contraceptionJ Womens Health (Larchmt)20071681171118017937570
   PubMed Web of Science ®Google Scholar
• WongCLFarquharCRobertsHProctorMOral contraceptive pill for primary dysmenorrhoeaCochrane Database Syst Rev20094CD002120
   Web of Science ®Google Scholar
• JohnsonNPHummelshojLWorld Endometriosis Society Montpellier ConsortiumConsensus on current management of endometriosisHum Reprod20132861552156823528916
   PubMed Web of Science ®Google Scholar
• BrownJKivesSAkhtarMProgestagens and anti–progestagens for pain associated with endometriosisCochrane Database Syst Rev20123CD00212222419284
   PubMed Web of Science ®Google Scholar
• LegroRSArslanianSAEhrmannDADiagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guidelineJ Clin Endocrinol Metab201398124565459224151290
   PubMed Web of Science ®Google Scholar
• JohnsonSRPremenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitionersObstet Gynecol2004104484585915458909
   PubMed Web of Science ®Google Scholar
• ClaytonAHSymptoms related to the menstrual cycle: diagnosis, prevalence, and treatmentJ Psychiatr Pract2008141132118212599
   PubMed Web of Science ®Google Scholar
• RapkinAJLewisEITreatment of premenstrual dysphoric disorderWomens Health (Lond Engl)20139653755624161307
   PubMedGoogle Scholar
• ElliottJEAbduljabarHMorrisMPresurgical management of dysmenorrhea and endometriosis in a patient with Mayer-Rokitansky-Kuster-Hauser syndromeFertil Steril2011962e86e8921718988
   PubMed Web of Science ®Google Scholar
• TanYHLethabyAPre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleedingCochrane Database Syst Rev201311CD01024124234875
   PubMed Web of Science ®Google Scholar
• SulakPJScowRDPreeceCRiggsMWKuehlTJHormone withdrawal symptoms in oral contraceptive usersObstet Gynecol200095226126610674591
   PubMed Web of Science ®Google Scholar
• HuqFYTvarkovaKArafaAKadirRAMenstrual problems and contraception in women of reproductive age receiving oral anticoagulationContraception201184212813221757053
   PubMed Web of Science ®Google Scholar
• AdegiteEAGoyalRKMurrayPJMarshalMSucatoGSThe management of menstrual suppression and uterine bleeding: a survey of current practices in the Pediatric Blood and Marrow Transplant ConsortiumPediatr Blood Cancer201259355355722331813
   PubMed Web of Science ®Google Scholar
• PeyvandiFGaragiolaIMenegattiMGynecological and obstetrical manifestations of inherited bleeding disorders in womenJ Thromb Haemost20119Suppl 123624521781260
   PubMed Web of Science ®Google Scholar
• JamesAHKouidesPAAbdul–KadirRVon Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panelAm J Obstet Gynecol2009201112. e11e1819481722
   PubMed Web of Science ®Google Scholar
• Samuels-ReidJScottRBPainful crises and menstruation in sickle cell diseaseSouth Med J19857843843853983658
   PubMed Web of Science ®Google Scholar
• ACOG Committee Opinion No 580: von Willebrand disease in womenObstet Gynecol201312261368137324264714
   PubMedGoogle Scholar
• Martin-JohnstonMKOkojiOYArmstrongATherapeutic amenorrhea in patients at risk for thrombocytopeniaObstet Gynecol Surv2008636395402 quiz 40518492296
   PubMed Web of Science ®Google Scholar
• KirkhamYAAllenLKivesSCacciaNSpitzerRFOrnsteinMPTrends in menstrual concerns and suppression in adolescents with developmental disabilitiesJ Adolesc Health201353340741223763962
   PubMed Web of Science ®Google Scholar
• HillardPJMenstrual suppression with the levonorgestrel intrauterine system in girls with developmental delayJ Pediatr Adolesc Gynecol201225530831322831901
   PubMed Web of Science ®Google Scholar
• CoffeeALSulakPJHillAJHansenDJKuehlTJClarkJWExtended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migrainesJ Womens Health (Larchmt)201423431031724450487
   PubMed Web of Science ®Google Scholar
• SulakPWillisSKuehlTCoffeeAClarkJHeadaches and oral contraceptives: impact of eliminating the standard 7-day placebo intervalHeadache2007471273717355491
   PubMed Web of Science ®Google Scholar
• VerrottiAD’EgidioCAgostinelliSVerrottiCPavonePDiagnosis and management of catamenial seizures: a reviewInt J Womens Health2012453554123071424
   PubMedGoogle Scholar
• StevensSJHardenCLHormonal therapy for epilepsyCurrent Neurology and Neuroscience Reports201111443544221451944
   PubMed Web of Science ®Google Scholar
• MattsonRHCramerJACaldwellBVSiconolfiBCTreatment of seizures with medroxyprogesterone acetate: preliminary reportNeurology1984349125512586540415
   PubMed Web of Science ®Google Scholar
• CaseAMReidRLEffects of the menstrual cycle on medical disordersArch Intern Med199815813140514129665348
   PubMedGoogle Scholar
• EnsomMHGender–based differences and menstrual cycle–related changes in specific diseases: implications for pharmacotherapyPharmacotherapy200020552353910809339
   PubMed Web of Science ®Google Scholar
• SimpsonGRoomesDHumphreyMDAnaphylactoid reactions associated with menstruation affecting two sistersMed J Aust2001175841541711700834
   PubMed Web of Science ®Google Scholar
• SchindlerAENon–contraceptive benefits of oral hormonal contraceptivesInt J Endocrinol Metab2013111414723853619
   PubMedGoogle Scholar
• Pereira–VegaASanchezJLGilFLPremenstrual asthma and symptoms related to premenstrual syndromeJ Asthma201047883584020874438
   PubMed Web of Science ®Google Scholar
• PeikertTGillespieDJCassiviSDCatamenial pneumothoraxMayo Clin Proc200580567768015887438
   PubMed Web of Science ®Google Scholar
• OvalleFVaughanTB3rdSohnJEGowerBCatamenial diabetic ketoacidosis and catamenial hyperglycemia: case report and review of the literatureAm J Med Sci2008335429830318414069
   PubMed Web of Science ®Google Scholar
• PalombaSOrioFJrMangusoFLeuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndromeFertil Steril20058341012102015820814
   PubMed Web of Science ®Google Scholar
• MulakATacheYLaraucheMSex hormones in the modulation of irritable bowel syndromeWorld J Gastroenterol201420102433244824627581
   PubMed Web of Science ®Google Scholar
• HeinigJSimonPWeissFUZimmerKPDomschkeWLerchMMTreatment of menstruation-associated recurrence of hereditary pancreatitis with pharmacologic ovarian suppressionAm J Med2002113216412133758
   PubMed Web of Science ®Google Scholar
• Powell-DunfordNCCudaASMooreJLCragoMSKellyAMDeusterPAMenstrual suppression for combat operations: advantages of oral contraceptive pillsWomens Health Issues2011211869121185993
   PubMed Web of Science ®Google Scholar
• Peragallo UrrutiaRCoeytauxRRMcBroomAJRisk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysisObstet Gynecol20131222 Pt 138038923969809
   PubMed Web of Science ®Google Scholar
• MillerLHughesJPContinuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trialObstet Gynecol2003101465366112681866
   PubMed Web of Science ®Google Scholar
• LidegaardONielsenLHSkovlundCWLokkegaardEVenous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001–2010BMJ2012344e299022577198
   PubMed Web of Science ®Google Scholar
• MillerLVerhoevenCHHoutJIExtended regimens of the contraceptive vaginal ring: a randomized trialObstet Gynecol2005106347348216135576
   PubMed Web of Science ®Google Scholar
• IsleyMMKaunitzAMUpdate on hormonal contraception and bone densityRev Endocr Metab Disord20111229310621559817
   PubMed Web of Science ®Google Scholar
• SchwalliePCAssenzoJRContraceptive use – efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 daysFertil Steril19732453313394698589
   PubMed Web of Science ®Google Scholar
• MolsaPKInducement of therapeutic amenorrhea in mentally retarded women: two-year follow-up studyAm J Ment Defic19869055915933953694
   PubMedGoogle Scholar
• WangCChenMFuFHuangMGonadotropin-releasing hormone analog cotreatment for the preservation of ovarian function during gonadotoxic chemotherapy for breast cancer: a meta-analysisPLoS One201386e6636023805216
   PubMed Web of Science ®Google Scholar
• ChenHLiJCuiTHuLAdjuvant gonadotropin–releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal womenCochrane Database Syst Rev201111CD00801822071842
   PubMed Web of Science ®Google Scholar
• HidalgoMBahamondesLPerrottiMDiazJDantas-MonteiroCPettaCBleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two yearsContraception200265212913211927115
   PubMed Web of Science ®Google Scholar
• RonnerdagMOdlindVHealth effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous useActa Obstet Gynecol Scand199978871672110468065
   PubMed Web of Science ®Google Scholar
• Abou-SettaAMHoustonBAl-InanyHGFarquharCLevonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgeryCochrane Database Syst Rev20131CD00507223440798
   PubMed Web of Science ®Google Scholar
• KelekciSKelekciKHYilmazBEffects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosisContraception201286545846322832203
   PubMed Web of Science ®Google Scholar
• KriplaniAAwasthiDKulshresthaVAgarwalNEfficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyomaInt J Gynaecol Obstet20121161353821959070
   PubMed Web of Science ®Google Scholar
• ShawRWA risk benefit assessment of drugs used in the treatment of endometriosisDrug Saf19941121041137945998
   PubMed Web of Science ®Google Scholar
• PinkertonJVPharmacological therapy for abnormal uterine bleedingMenopause201118445346121701432
   PubMed Web of Science ®Google Scholar